UNSPSC 85892124: High dose rate (hdr) brachytherapy of nasopharynx using cesium 137 (cs-137)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of nasopharynx using cesium 137 (cs-137). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D91D97Z

UNSPSC 85892124, High dose rate brachytherapy of nasopharynx using cesium 137, is a Commodity code that shows little relevant recent state and local procurement activity. The most recent opportunity tagged to this code—Santa Clara County Health System's July 2026 RFQ for temporary health professional staffing services across ancillary clinical categories (Audiology, Cardiology, Diagnostic Imaging, Gastroenterology, Orthopedic, Respiratory Care, Surgical/Operating Room, and Therapy Services)—addresses general clinical workforce staffing rather than specialized cancer treatment services or medical equipment procurement. The mismatch between the code's nominal scope (radiation therapy for nasopharyngeal cancer) and the actual work being solicited suggests the code carries minimal relevance to current state and local procurement activity.

No additional recent opportunities under this code appear in the available records. Firms evaluating this Commodity code should monitor whether state and local health systems, hospital networks, or cancer treatment facilities begin soliciting specialized oncology equipment, radiation therapy services, or related medical procedures directly. Until such activity emerges, this code does not represent an active procurement avenue for state and local business development.